Primaeva Medical

Pleasanton, United States Founded: 2005 • Age: 21 yrs Acquired By Candela Medical
Aesthetic treatment devices for dermatologists and cosmetic surgeons

About Primaeva Medical

Primaeva Medical is a Healthcare company based in Pleasanton (United States) founded in 2005, and was acquired by Candela Medical in October 2009. Aesthetic treatment devices for dermatologists and cosmetic surgeons. Primaeva Medical has raised $14.25 million across 3 funding rounds from investors including Candela Medical, Frazier Healthcare Partners and Delphi Ventures. The company was acqui-hired. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its legal entity is Primaeva Medical Inc. Its competitors include ThermiGen, EndyMed and Serene Medical; 2 of its 3 listed competitors have raised funding.

Company details

Primaeva Medical was a privately held venture capital-funded company developing devices for dermatologists, plastic surgeons, and other cosmeticaesthetic physicians. It developed a minimally invasive RF aesthetic device for the treatment of skin wrinkles and laxity. Was acquired by Syneron in 2009.

Operational Areas
Key Metrics

Funding Insights of Primaeva Medical

Primaeva Medical has successfully raised a total of $14.25M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $6 million completed in February 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $14.25M
  • Total Rounds 3
  • Last Round Series C β€” $6M
  • First Round $1.25M

    (Jun 2006)

  • Investors Count 3

All 3 funding rounds of Primaeva Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2009$6MSeries C–Affinity Capital Management
Dec 2006$7MSeries B––
Jun 2006$1.25MSeries A––
Valuation history

4 investors in total: 4 institutional.

Investors in Primaeva Medical

Primaeva Medical has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Candela Medical, Frazier Healthcare Partners and Delphi Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investments are made in life sciences firms across all stages.
delphiventures.comMenlo Park, United States
Healthcare sector private equity investments are managed by the firm.
1991frazierhealthcare.comSeattle, United States
affinitycapital.net
Multiple medical devices for dermatological health are developed.
1970candelamedical.comAmsterdam, Netherlands
Premium access

Investor details for Primaeva Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Primaeva Medical

4 dated milestones of Primaeva Medical across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Primaeva Medical is founded.
  2. Funding First funding round of $1.2M.
  3. Funding Latest funding round, Series C, of $6.0M.
  4. Exit Acquired by Candela Medical.

Competitors of Primaeva Medical

Primaeva Medical has 3 listed competitors in our database, 2 of them funded. They include ThermiGen, EndyMed and Serene Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
thermi.com2012Austin, United States$8M79
Thermistor-regulated energy systems are developed for aesthetic and dermatology uses.
endymed.com2007New York, United States
Radiofrequency-based systems for aesthetic skin treatments are developed.
serenemedical.com2010San Ramon, United States$3M
Handheld device for selective modulation of target motor nerves to treat aesthetic conditions.
Premium access

Detailed competitors of Primaeva Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Dermatology

3 companies that operate in the same segment as Primaeva Medical (Dermatology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Primaeva Medical

Primaeva Medical was founded in 2005 and raised its 1st funding round 1 year after it was founded.

Primaeva Medical is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.

Primaeva Medical is a funded company, having raised a total of $14.25M across 3 funding rounds to date. The company's 1st funding round was a Series A of $1.25M, raised on Jun 2006.

Primaeva Medical was a privately held venture capital-funded company developing devices for dermatologists, plastic surgeons, and other cosmeticaesthetic physicians. It developed a minimally invasive RF aesthetic device for the treatment of skin wrinkles and laxity. Was acquired by Syneron in 2009.

Primaeva Medical's top competitors include ThermiGen, EndyMed and Serene Medical.

Primaeva Medical has 4 investors. Key investors include Candela Medical, Frazier Healthcare Partners, Delphi Ventures, and Affinity Capital Management.

Primaeva Medical operates through Primaeva Medical Inc.

Yes. Primaeva Medical was acquired by Candela Medical in October 2009.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available